SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 34 filers reported holding SIGILON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $279,878 | +165.7% | 300,912 | 0.0% | 0.00% | – |
| Q4 2022 | $105,319 | -30.7% | 300,912 | 0.0% | 0.00% | – |
| Q3 2022 | $152,000 | -25.5% | 300,912 | +22.3% | 0.00% | – |
| Q2 2022 | $204,000 | -55.3% | 246,142 | -20.7% | 0.00% | – |
| Q1 2022 | $456,000 | -68.8% | 310,502 | -41.4% | 0.00% | – |
| Q4 2021 | $1,461,000 | -35.9% | 529,559 | +31.3% | 0.00% | – |
| Q3 2021 | $2,278,000 | -40.7% | 403,183 | +12.7% | 0.00% | – |
| Q2 2021 | $3,839,000 | -53.4% | 357,807 | -3.0% | 0.00% | – |
| Q1 2021 | $8,241,000 | +390.2% | 368,737 | +953.5% | 0.00% | – |
| Q4 2020 | $1,681,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 740,740 | $35,578,000 | 13.90% |
| Flagship Pioneering Inc. | 10,370,369 | $498,089,000 | 9.07% |
| Monashee Investment Management LLC | 561,628 | $26,975,000 | 3.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 567,460 | $26,061,000 | 2.31% |
| Avidity Partners Management LP | 688,000 | $33,045,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 225,000 | $10,807,000 | 0.76% |
| Artal Group S.A. | 276,000 | $13,256,000 | 0.28% |
| GILDER GAGNON HOWE & CO LLC | 662,227 | $31,807,000 | 0.16% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,485,185 | $71,333,000 | 0.11% |
| Perceptive Advisors | 125,000 | $6,004,000 | 0.06% |